Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 XW023X7
ICD-10-PCS code XW023X7 for Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 is a medical classification as listed by CMS under Anatomical Regions range.
Official Code Descriptor
Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7
Crosswalks
Tabs
No record found
Crosswalk an ICD-10-PCS code to CPT®
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Body Part(2) | Approach(3) | Device / Substance / Technology(X) | Qualifier(7) |
| New Technology | Anatomical Regions | Introduction | Muscle | Percutaneous | Peptide Enhanced Bone Void Filler | New Technology Group 7 |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Added | 10-01-2021 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
